Akin Atmaca

6.2k citations
65 papers · 3.4k · 2 hit papers · h-index 24

Impact in

  • Oncology top 1%
    • Lung Cancer Research Studies
    • Cancer Immunotherapy and Biomarkers
    • Peptidase Inhibition and Analysis
    • Colorectal Cancer Treatments and Studies
    • Gastric Cancer Management and Outcomes
    • Lung Cancer Treatments and Mutations

Papers in

    • Cancer Immunotherapy and Biomarkers 13
    • Lung Cancer Research Studies 10
    • CAR-T cell therapy research 4
    • Lung Cancer Treatments and Mutations 10
    • Gastric Cancer Management and Outcomes 7

Akin Atmaca

59 papers receiving 3.4k citations

Akin Atmaca's Hit Papers

Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer 2018 · 689 citations
6890+6+12Years since publication200400600

Peers

Akin Atmaca
Comparison fields: 5 of 87
  • Oncology 1.8k
  • Pulmonary and Respiratory Medicine 1.1k
  • Gastroenterology 165
  • Immunology 468
  • Cancer Research 228
Replace T Kabuto with:
T Kabuto Japan
Caroline S. Verbeke Norway
Atsuo Takashima Japan
T Kosuge Japan
An Na Seo South Korea
Feng‐Hua Wang China
Sebastian Aulmann Germany
María Alsina Spain
Norihiro Masuda Japan
Young Soo Park South Korea
Akin Atmaca relative to T Kabuto Japan T Kabuto's profile →
Citations per field
00.5×10×15×18×
T Kabuto · 1×
Citations per year

Countries citing papers authored by Akin Atmaca

Since Specialization
Citations

This map shows the geographic impact of Akin Atmaca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akin Atmaca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akin Atmaca more than expected).

Fields of papers citing papers by Akin Atmaca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akin Atmaca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akin Atmaca. The network helps show where Akin Atmaca may publish in the future.

Co-authors

The 25 scholars most cited alongside Akin Atmaca, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Akin Atmaca Line = papers co-authored together Akin Atmaca links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer
Hit paper breakdown →
2018689
2
Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie
Hit paper breakdown →
2008584
3 2018239
4 2019225
5 2008186
6 2007164
7 2004158
8 200579
9 201178
10 201169
11 201068
12 201762
13 200660
14 201656
15 200553
16
LUD 00-009: phase 1 study of intensive course immunization with NY-ESO-1 peptides in HLA-A2 positive patients with NY-ESO-1-expressing cancer.
200748
17 201345
18 200645
19 201244
20 200831

About Akin Atmaca

Akin Atmaca is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Immunology, Molecular Biology and Pediatrics, Perinatology and Child Health, having authored 65 papers that have together received 3.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (15 papers), Cancer Immunotherapy and Biomarkers (13 papers), Lung Cancer Research Studies (10 papers), Lung Cancer Treatments and Mutations (10 papers), Gastric Cancer Management and Outcomes (7 papers), Histone Deacetylase Inhibitors Research (6 papers), Immune Cell Function and Interaction (4 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Oncology (1.8k citations), Pulmonary and Respiratory Medicine (1.1k citations), Gastroenterology (165 citations), Immunology (468 citations) and Cancer Research (228 citations). Akin Atmaca has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Elke Jäger, Alexander Knuth, Salah‐Eddin Al‐Batran, Claudia Pauligk, Scott Antonia, Matthew D. Hellmann, Margaret K. Callahan, Emiliano Calvo, Paolo A. Ascierto and G. Seipelt. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Journal of Thoracic Oncology and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact